These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12579267)

  • 1. Immunohistochemical analysis of transforming growth factor beta in gallbladder cancer.
    Kitamura K; Kasuya K; Tsuchida A; Mimuro A; Inoue K; Aoki T; Aoki T; Koyanagi Y
    Oncol Rep; 2003; 10(2):327-32. PubMed ID: 12579267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
    Netto GC; Bleil CB; Hilbig A; Coutinho LM
    Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor angiogenesis in gallbladder carcinoma.
    Sugawara Y; Makuuchi M; Harihara Y; Noie T; Inoue K; Kubota K; Takayama T
    Hepatogastroenterology; 1999; 46(27):1682-6. PubMed ID: 10430321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer.
    Wikström P; Lissbrant IF; Stattin P; Egevad L; Bergh A
    Prostate; 2002 Jun; 51(4):268-75. PubMed ID: 11987155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
    Li C; Gardy R; Seon BK; Duff SE; Abdalla S; Renehan A; O'Dwyer ST; Haboubi N; Kumar S
    Br J Cancer; 2003 May; 88(9):1424-31. PubMed ID: 12778073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
    Fonsatti E; Del Vecchio L; Altomonte M; Sigalotti L; Nicotra MR; Coral S; Natali PG; Maio M
    J Cell Physiol; 2001 Jul; 188(1):1-7. PubMed ID: 11382917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms.
    Henriksen R; Gobl A; Wilander E; Oberg K; Miyazono K; Funa K
    Lab Invest; 1995 Aug; 73(2):213-20. PubMed ID: 7637321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
    Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
    Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of angiogenesis by Chalkley counting in gallbladder carcinoma.
    da Rocha AO; Coutinho LM; Schall JG
    Hepatogastroenterology; 2009; 56(89):34-8. PubMed ID: 19453024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
    Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
    Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells.
    She X; Matsuno F; Harada N; Tsai H; Seon BK
    Int J Cancer; 2004 Jan; 108(2):251-7. PubMed ID: 14639611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
    Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
    Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoglin (CD105) expression in the development of haemorrhoids.
    Chung YC; Hou YC; Pan AC
    Eur J Clin Invest; 2004 Feb; 34(2):107-12. PubMed ID: 14764073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(4A):2701-10. PubMed ID: 9703932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD105 is important for angiogenesis: evidence and potential applications.
    Duff SE; Li C; Garland JM; Kumar S
    FASEB J; 2003 Jun; 17(9):984-92. PubMed ID: 12773481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1.
    Gohongi T; Fukumura D; Boucher Y; Yun CO; Soff GA; Compton C; Todoroki T; Jain RK
    Nat Med; 1999 Oct; 5(10):1203-8. PubMed ID: 10502827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transforming growth factor beta and transforming growth factor beta receptors on AIDS-associated Kaposi's sarcoma.
    Ciernik IF; Krayenbühl Ciernik BH; Cockerell CJ; Minna JD; Gazdar AF; Carbone DP
    Clin Cancer Res; 1995 Oct; 1(10):1119-24. PubMed ID: 9815902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
    Ho CL; Sheu LF; Li CY
    Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
    Raica M; Cimpean AM; Anghel A
    Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.